Singapore approves use of world's first dengue vaccine

By LINETTE LAI

- AFP

SINGAPORE: The Health Sciences Authority (HSA) has approved the world's first dengue vaccine Dengvaxia for use in Singapore following a seven-month expedited review of the potential benefits and risks.

It will be made commercially available in several months' time.

Get 30% off with our ads free Premium Plan!

Monthly Plan

RM13.90/month
RM9.73 only

Subscribe

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Subscribe

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only

Subscribe
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Health , Singapore , Health Sciences Authority , Dengue fever , Vaccine , Dengvaxia

   

Report it to us.

Next In Regional
Acting legend Tony Leung, Nvidia chief Huang get honorary doctorates from HK uni
India reports 'good progress' in Asean-India trade pact review talks
KL in 50th spot as London crowned world's best city for 10th consecutive year
Malaysia commends Laos for successful Asean 2024 chairmanship
Supply chain snags: Airlines in Malaysia, Thailand among those affected as travel demand rebounds
41 passengers injured as Hong Kong ferry bumps into pier on Central’s waterfront
DPM Zahid emphasises shared goals in meeting with Philippines President Marcos
Malaysia’s strategies as Asean chair in 2025 focus on regional value chains, says Anwar
Asean Foreign Ministers' meeting kicks off in Laos ahead of 44th and 45th Asean Summits
Asean must remain neutral to boost regional investment, says Tengku Zafrul

Trending in News

Others Also Read

Load more

Copyright © 1995- Star Media Group Berhad [197101000523 (10894-D)]

Best viewed on Chrome browsers.